Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI106121

Cellular transport of l-histidine in Hartnup disease

Sverre Halvorsen, Olof Hygstedt, Rudolf Jagenburg, and Ottar Sjaastad

Children's Hospital and Pediatric Research Institute, Rikshospitalet, Oslo, Norway

Department of Medical Biochemistry, University of Gothenburg, Gothenburg, Sweden

Department of Clinical Chemistry, University of Gothenburg, Gothenburg, Sweden

Find articles by Halvorsen, S. in: PubMed | Google Scholar

Children's Hospital and Pediatric Research Institute, Rikshospitalet, Oslo, Norway

Department of Medical Biochemistry, University of Gothenburg, Gothenburg, Sweden

Department of Clinical Chemistry, University of Gothenburg, Gothenburg, Sweden

Find articles by Hygstedt, O. in: PubMed | Google Scholar

Children's Hospital and Pediatric Research Institute, Rikshospitalet, Oslo, Norway

Department of Medical Biochemistry, University of Gothenburg, Gothenburg, Sweden

Department of Clinical Chemistry, University of Gothenburg, Gothenburg, Sweden

Find articles by Jagenburg, R. in: PubMed | Google Scholar

Children's Hospital and Pediatric Research Institute, Rikshospitalet, Oslo, Norway

Department of Medical Biochemistry, University of Gothenburg, Gothenburg, Sweden

Department of Clinical Chemistry, University of Gothenburg, Gothenburg, Sweden

Find articles by Sjaastad, O. in: PubMed | Google Scholar

Published August 1, 1969 - More info

Published in Volume 48, Issue 8 on August 1, 1969
J Clin Invest. 1969;48(8):1552–1559. https://doi.org/10.1172/JCI106121.
© 1969 The American Society for Clinical Investigation
Published August 1, 1969 - Version history
View PDF
Abstract

The urinary excretion, the intestinal absorption, and the elimination of histidine from blood were studied in two patients with Hartnup disease. On standard diet the patients lost a great proportion of the dietary histidine in the urine, whereas the fecal loss was negligible. A high oral dose of L-histidine gave only a slight increase in plasma histidine and no increase in fecal histidine, but a considerable increase in the urinary histidine output. Intravenously administered L-histidine was eliminated more rapidly than in controls. The lack of increase in plasma histidine after the oral loading may be explained by the rapid elimination from the blood. This was mainly due to a rapid cellular uptake of histidine which is supposed to be a normal reaction of histidine-deprived cells. Thus the only obvious defect in the histidine transport in Hartnup disease is the reabsorption defect in the renal tubules. A generally impaired cellular transport of L-histidine is improbable.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1552
page 1552
icon of scanned page 1553
page 1553
icon of scanned page 1554
page 1554
icon of scanned page 1555
page 1555
icon of scanned page 1556
page 1556
icon of scanned page 1557
page 1557
icon of scanned page 1558
page 1558
icon of scanned page 1559
page 1559
Version history
  • Version 1 (August 1, 1969): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts